BIOA - BioAmber Inc.

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
CategoryN/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • PR Newswire

    BioArctic Strengthens its Management Team With Two Strategic Recruitments

    BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will be strengthening its management team in 2020 through two strategic recruitments. As of January 1, Tomas Odergren will assume the role of Chief Medical Officer and as of May 18, Oskar Bosson will assume the role of VP Communications & IR. Tomas Odergren has significant experience from senior positions including at AstraZeneca, Lundbeck and most recently at BioArctic. Oskar Bosson joins BioArctic from his previous role as Executive Vice President Communication & Public Affairs at Elekta AB.

  • ACCESSWIRE

    BioAmber, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 16, 2018 / BioAmber, Inc. OTC PINK: BIOA ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 16, 2018, at 8:00 AM Eastern Time. To ...

  • ACCESSWIRE

    BioAmber, Product Development, Financial Review, TSX Issue, Analysts Target

    NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...